Commission Implementing Regulation (EU) 2025/1490of 24 July 2025amending Implementing Regulation (EU) No 564/2013 as regards the adaptation of fees to inflation(Text with EEA relevance)

Commission Implementing Regulation (EU) 2025/1490 of 24 July 2025 amending Implementing Regulation (EU) No 564/2013 as regards the adaptation of fees to inflation (Text with EEA relevance) THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products OJ L 167, 27.6.2012, p. 1, ELI: http://data.europa.eu/eli/reg/2012/528/oj. , and in particular Article 80(1) thereof, Whereas: (1) In accordance with Article 17 of Commission Implementing Regulation (EU) No 564/2013 Commission Implementing Regulation (EU) No 564/2013 of 18 June 2013 on the fees and charges payable to the European Chemicals Agency pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council concerning the making available on the market and use of biocidal products (OJ L 167, 19.6.2013, p. 17, ELI: http://data.europa.eu/eli/reg_impl/2013/564/oj). , the fees provided for in that Regulation are to be reviewed annually by reference to the inflation rate as measured by means of the European Index of Consumer Prices as published by Eurostat. (2) In order to perform this annual review for the year 2024, the fees should be adjusted in accordance with the average annual inflation rates for 2021, 2022 and 2023, as published by Eurostat, so as to reflect the cumulative inflation rate of 19,5 %. (3) Implementing Regulation (EU) No 564/2013 should therefore be amended accordingly. (4) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products, HAS ADOPTED THIS REGULATION:

Article 1

Regulation (EU) No 564/2013 is amended as follows: (1) Annexes I and II are amended in accordance with Annex I to this Regulation; (2) Annex III is replaced by the text set out in Annex II to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Brussels, 24 July 2025. For the Commission The President Ursula von der Leyen

Annex

ANNEX I Annexes I and II of Regulation (EU) No 564/2013 are amended as follows: (1) in Annex I, Table 1 is replaced with the following: Table 1 Standard fees Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 294, 10.10.2014, p. 1, ELI: http://data.europa.eu/eli/reg_del/2014/1062/oj). General description of task; relevant provision in Regulation (EU) No 528/2012Specific condition or task descriptionFee (EUR)Approval of an active substance; Article 7(2)Fee for the first product-type for which that active substance is approved143400Additional fee per additional product-type47800Additional fee per product-type (for both the first product-type and any additional product-type) if the active substance is a candidate for substitution in accordance with Article 10 of Regulation (EU) No 528/201223900Fee for the amendment of an approval, other than the addition of a product-type23900Renewal of an approval; Article 13(3)Fee for the first product-type for which renewal of that active substance is sought17925Additional fee per additional product-type1793Additional fee for the first product-type for which renewal of that active substance is sought in case a full evaluation is found necessary in accordance with Article 14(1) of Regulation (EU) No 528/201229875Additional fee per additional product-type in case a full evaluation is found necessary in accordance with Article 14(1) of Regulation (EU) No 528/20122988Additional fee per product-type (for both the first product-type and any additional product-type) if the active substance is a candidate for substitution in accordance with Article 10 of Regulation (EU) No 528/201223900Inclusion in Annex I of an active substance; Article 28Fee for the first inclusion in Annex I of an active substance11950Fee for the amendment of an inclusion of an active substance in Annex I2390Notification in accordance with Article 17(4) of Commission Delegated Regulation (EU) No 1062/2014

Fee per substance/product-type combination. The fee for the notification shall be deducted from the subsequent application for approval 11950 (2) in Annex II, Table 1 is replaced with the following: Table 1 Standard fees Commission Implementing Regulation (EU) No 414/2013 of 6 May 2013 specifying a procedure for the authorisation of same biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 125, 7.5.2013, p. 4., ELI: http://data.europa.eu/eli/reg_impl/2013/414/oj). Commission Implementing Regulation (EU) No 354/2013 of 18 April 2013 on changes of biocidal products authorised in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 109, 19.4.2013, p. 4, ELI: http://data.europa.eu/eli/reg_impl/2013/354/oj). General description of task; relevant provision in Regulation (EU) No 528/2012Specific condition or task descriptionFee (EUR)Granting of Union authorisation, single product; Article 43(2)Fee per product not identical with (one of) the representative product(s) assessed for the purpose of the substance approval95600Fee per product identical with (one of) the representative product(s) assessed for the purpose of the substance approval47800Additional fee per product when comparative assessment in accordance with Article 23 of Regulation (EU) No 528/2012 is required47800Additional fee per product when the requested authorisation is provisional in accordance with Article 55(2) of Regulation (EU) No 528/201211950Granting of Union authorisation, biocidal product family; Article 43(2)Fee per family179250Additional fee per family when comparative assessment in accordance with Article 23 of Regulation (EU) No 528/2012 is required71700Additional fee per family when the requested authorisation is provisional in accordance with Article 55(2) of Regulation (EU) No 528/201217925Notification to the Agency of an additional product within a biocidal product family; Article 17(6)Fee per additional product2390Union authorisation of a same biocidal product; Article 17(7)Fee per product constituting a same product within the meaning of Commission Implementing Regulation (EU) No 414/20132390Major change of an authorised product or product family; Article 50(2)Fee per application47800Minor change of an authorised product or product family; Article 50(2)Fee per application17925Administrative change of an authorised product or product family; Article 50(2)Fee per notification2390Recommendation on the classification of a change of an authorised product or product family; Article 50(2) Fee per request in accordance with Commission Implementing Regulation (EU) No 354/2013 If the recommendation is to classify the change as an administrative or minor change, the fee for the request shall be deducted from the subsequent application or notification in accordance with Implementing Regulation (EU) No 354/2013 2390 Renewal of Union authorisation, single product; Article 45(3)Fee per product5975Additional fee per product in case a full evaluation is found necessary in accordance with Article 14(1) of Regulation (EU) No 528/201217925Additional fee per product when comparative assessment in accordance with Article 23 of Regulation (EU) No 528/2012 is required47800Renewal of Union authorisation, biocidal product family; Article 45(3)Fee per product family8963Additional fee per product family in case a full evaluation is found necessary in accordance with Article 14(1) of Regulation (EU) No 528/201226888Additional fee per product family when comparative assessment in accordance with Article 23 of Regulation (EU) No 528/2012 is required71700

Annex

ANNEX II

Annex

ANNEX III Other fees General description of task; relevant provision in Regulation (EU) No 528/2012Specific condition or task descriptionFee (EUR)Technical equivalence; Article 54(3)Fee, when difference between the active substance sources is limited to a change in manufacturing location, and application is based solely on analytical data5975Fee, when difference between the active substance sources goes beyond a change in the manufacturing location, and application is based solely on analytical data23900Fee when previous conditions are not met.47800Annual fee for biocidal products authorised by the Union; Article 80(1)(a)Fee per Union authorisation of a biocidal product11950Fee per Union authorisation of a biocidal product family23900Mutual Recognition Submission fee; Article 80(1)(a)Fee per product or product family concerned by an application for mutual recognition, per Member State where mutual recognition is sought837Appeal; Article 77(1)Fee per appeal2988Submission for inclusion in the list of relevant persons; Article 95Fee per submission of a letter of access to a dossier already found complete by the Agency or an evaluating Competent Authority2390Fee per submission of a letter of access to part of a dossier already found complete by the Agency or an evaluating Competent Authority, together with complementary data23900Fee per submission of a new dossier47800Requests under Article 66(4) submitted to the AgencyFee per item for which confidentiality is requested1195